Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2008
07/31/2008WO2007002830A3 Diagnosis of and protection from hyperinsulinemia and type ii diabetes
07/31/2008WO2006063065A3 Detection of nucleic acids from multiple types of human papillomaviruses
07/31/2008US20080184397 Acquired Resistance Genes in Plants
07/31/2008US20080184392 Transforming a plant cell with a nucleic acid sequence that encodes the acquired resistance polypeptide, regenerating a plant from the transformed plant cell; resistance to fungal pathogens
07/31/2008US20080184390 Expression cassettes for mesophyll-and/or epidermis-preferential expression in plants
07/31/2008US20080184387 in plants obtainable from Arabidopsis thaliana genes; for alteration of the function of root tissue, modification of growth rate, improvement of resistance to root preferred pathogens, pests, herbicides or adverse weather conditions, for detoxification of soil as well as for broadening the range of soils
07/31/2008US20080184381 Schizophrenia-related voltage-gated ion channel gene and protein
07/31/2008US20080184379 screening inductive promoting substances of anti-viral proteins such as interferon-beta against lipopolysaccharide stimulation or viral infection by using TBK1 knockout mice, or the tissues or cells derived therefrom
07/31/2008US20080183395 Using RNA expression patterns as diagnostic tool in detection of infection and inflammatory disorders; predicting an increased risk to an adverse effect from anti-TNF therapy
07/31/2008US20080183394 Polymorphisms in mitochondrial transcription factor A ("TFAM") gene and their associations with carcass traits
07/31/2008US20080182980 Reactive Functional Groups
07/31/2008US20080182977 Molecules associated with cell proliferation
07/31/2008US20080182970 Using cypin in assays, diagnostics and treatment of cognitive disorders
07/31/2008US20080182895 Identification and characterization of hcv replicon variants with reduced susceptibility to hcv-796, and methods related thereto
07/31/2008US20080182805 O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-Acetyl moiety
07/31/2008US20080182801 Core 2 glcnac-t inhibitors
07/31/2008US20080182799 Botulinum toxin screening assays
07/31/2008US20080182792 Diminishing presence of protein aggregates in an environment susceptible to formation of protein aggregate by introducing into environment a compound having two domains, a first domain that binds to protein aggregation having two monomers, and a second domain binding to diminishing protein
07/31/2008US20080182788 Compositions and Methods for Increasing Bone Mineralization
07/31/2008US20080182784 Reduction or mutation in kalirin indicates senile dementia related to diabetes; Alzheimer's disease; inhibiting nitric oxide cytotoxicity
07/31/2008US20080182779 Apelin and uses thereof
07/31/2008US20080182778 Identification of an Evolutionarily Conserved Pathway Mediating Transrepression of Inflammatory Response Genes by Nuclear Receptors
07/31/2008US20080182777 Regulation of cell migration and adhesion
07/31/2008US20080182331 Production of transgenic animals; targeted replacement of an endogenous gene; genetic trait expression; DNA gene inactivation construct
07/31/2008US20080182324 using an enzyme-coenzyme complex as stoichiometric reactant instead of, as usual, as catalyst; Detection of the analyte requires only a single reaction step and is therefore extremely fast
07/31/2008US20080182314 Neuronal serine threonine protein kinase
07/31/2008US20080182300 Kit comprising RNA/DNA hybrid primer, template switch oligonucleotides (TSO) and cyclical replication of RNA sequences
07/31/2008US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy
07/31/2008US20080182291 Diagnosis of constipation by analysis of methane concentration
07/31/2008US20080182290 Apparatus and methods for determining viability of cell-based products
07/31/2008US20080182289 High-Throughput Screen For Identifying Selective Persistent Sodium Channels Channel Blockers
07/31/2008US20080182288 High-Throughput Screen For Identifying Selective Persistent Sodium Channels Channel Blockers
07/31/2008US20080182287 Gel Formulations and Uses Thereof
07/31/2008US20080182286 Using analyte-specific oxidase immobilized on solid support comprised of protein-impermeable, hydrophilic matrix to determine glucose concentration of blood; diabetes screening
07/31/2008US20080182285 Measuring alpha -amylase even in sample comprising animal alpha -amylase and glucoamylase without diluting; using an oligosaccharide having a protected nonreducing terminus and a p-nitrophenyl group at the reducing terminus
07/31/2008US20080182284 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
07/31/2008US20080182283 Inhibitors of human plasmin derived from the kunitz domains
07/31/2008US20080182282 Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same
07/31/2008US20080182278 Identification and isolation of transitional cell carcinoma stem cells
07/31/2008US20080182276 Method and Quantification Assay for Determining c-kit/SCF/pAKT Status
07/31/2008US20080182272 Rapid resuscitation, growth, capture and detection of microorganisms
07/31/2008US20080182269 utilize promoter hairpin constructs to suppress gene expression and thereby identify function of a gene of interest; useful for generating fertile parental plants that when crossed generate sterile progeny plants
07/31/2008US20080182268 Schizophrenia associated genes, proteins and biallelic markers
07/31/2008US20080182267 Method for predicting a drug transport capability by abcg2 polymorphisms
07/31/2008US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells
07/31/2008US20080182265 Method for measuring the number of oral streptococci and a pcr primers-probe set used for the same
07/31/2008US20080182264 Systems and Methods for Baseline Correction Using Non-Linear Normalization
07/31/2008US20080182263 Systems and Methods for Calibration Using Dye Signal Amplification
07/31/2008US20080182262 simultaneous determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, and the identification of cellular subsets that exhibit correlated changes
07/31/2008US20080182261 detecting the presence or absence of the fetal DNA sequence of interest in fetal DNA derived from a sample of peripheral blood obtained from a pregnant woman is described. The method involves obtaining a sample peripheral blood from a pregnant woman, treating the sample of peripheral blood
07/31/2008US20080182260 Method for quantifying a ratio between at least two nucleic acid sequences
07/31/2008US20080182259 Method for judging lymph node metastasis of stomach cancer and kit used therefor
07/31/2008US20080182258 Q3 sparc deletion mutant and uses thereof
07/31/2008US20080182257 detecting melanoma. The methods comprises detecting a gain or loss of certain chromosomal regions that undergo copy number changes in melanoma.
07/31/2008US20080182256 Kit for identifying mobile genetic element insertional event which subsequently generates insect resistant monocot crop plant
07/31/2008US20080182255 Gene Expression Profiling in Biopsied Tumor Tissues
07/31/2008US20080182254 Detection of Nucleic Acids By Multiple Sequential Invasive Cleavages
07/31/2008US20080182253 Automated method for detecting cancers and high grade hyperplasias
07/31/2008US20080182252 Genotyping Hla Loci
07/31/2008US20080182251 Ultra Low Strength Electric Field Network-Mediated Ex Vivo Gene, Protein and Drug Delivery in Cells
07/31/2008US20080182250 Method for detecting multiple myeloma and method for inhibiting the same
07/31/2008US20080182249 Expression system for components of a desaturase complex is provided. The system includes expression of a desaturase and an oxidoreductase. The system may be used for expression of mycobacterial desaturases for expression of mammalian desaturases.
07/31/2008US20080182248 Parallel genotyping of multiple patient samples
07/31/2008US20080182247 diagnosing, monitoring and/or treating an autoimmune or chronic inflammatory disease. In particular, the present invention provides methods for diagnosing, monitoring and treating an autoimmune disease (e.g., rheumatoid arthritis) or chronic inflammatory disease (e.g., systemic lupus erythematosus) based
07/31/2008US20080182246 method for predicting distant metastasis of lymph node negative primary breast cancer by obtaining breast cancer cells; isolating nucleic acid and/or protein from the cells; and analyzing the nucleic acid and/or protein to determine the presence, expression level or status of a Biomarker
07/31/2008US20080182245 Methods and Compositions Involving MicroRNA
07/31/2008US20080182244 Pre-Implantation Genetic Diagnosis Test
07/31/2008US20080182243 Systems for genome selection
07/31/2008US20080182242 Dominant-negative alleles of human mismatch repair genes can be used to generate hypermutable cells and organisms. By introducing these genes into mammalian cells new cell lines with novel and useful properties can be prepared more efficiently than by relying on the natural rate of mutation
07/31/2008US20080182241 Identification and use of cytochrome p450 nucleic acid sequences from tobacco
07/31/2008US20080182240 Uses And methods of making Microarrays of Polymeric biomaterials
07/31/2008US20080182239 nucleic acids, compositions, and kits for detecting microRNA (miRNA) in samples. The methods comprise designing mRNA-specific primers, adding a polyA tail to the miRNA, and using reverse transcription and amplification to detect the miRNA. The nucleic acids, compositions, and kits
07/31/2008US20080182238 conducting a biochemical assay that allows for a reduction of assay interferences. The method comprises treating a mixture of cell sample and cell constituents solubilizing agent, with an insoluble agent prior to conducting the assay. There is also provided a device as well as a kit for analyzing
07/31/2008US20080182237 MiRNAs; diagnosis, prognosis, and treatments; drug screening; linear amplification and labeling for hybridization techniques like Luminex and Microarray analysis; gene expression inhibition
07/31/2008US20080182236 Within human chromosome 7p15-p14; GPRA polypeptides, nucleic acids, host cells, primers and probes; transgenic animal models; anticarcinogenic agents; chronic obstructive pulmonary disorder; diagnosis; analyzing allelic variation in the locus and GPRA gene
07/31/2008US20080182235 Incubating a luminescence-related amplificant encapsulated within said liposomes, a buffer and paramagnetic beads; separating; treating with extractant; measuirng emitted light from assay sample; early detection of disease-causing microorganisms
07/31/2008US20080182234 Methods and Compositions for Modulating Adenosine Triphosphate (ATP) in Cells and Preventing Cell Injury or Death via Post-translational Modifications to ATP Synthase
07/31/2008US20080181965 polymeric particles made of copolymeric butyl acrylate, divinylbenzene, ethylstyrene, and poly(ethylene glycol) monomethyl ether methacrylate conjugated with peptide; protein; polysaccharide; nucleotide; oligonucleotide; nucleic acid; hapten; drug; biocompatible, resistant to adhesion of serum protein
07/31/2008US20080181918 Immunogens; vaccines; fusion proteins
07/31/2008US20080181907 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
07/31/2008US20080181898 Wise/sost nucleic acid sequences and amino acid sequences
07/31/2008US20080181896 Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers
07/31/2008US20080181894 Tumor/cancer antigens; solid phase synthesis; drug screening
07/31/2008US20080181885 202P5A5 gene or fragment or its encoded protein, or variants , or a fragment, used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 be used in active or passive immunization; gene therapy, immunotherapy; anticarcinogenic agent biodrug for pancreatic cancer
07/31/2008US20080181877 bioassay of forskolin or phorbol 12-myristate 13-acetate; increase sensitivity of the protein kinase A signalling pathway, increase insulin sensitivity, thermogenesis; obesity, type 2 diabetes, insulin resistance, hypertriglyceridemia, cancer, increase plasma levels of free fatty acids
07/31/2008US20080181872 adeno-associated virus vector biodrug for Parkinson's disease, Huntington's disease, Alzheimer's disease, Down syndrome, rheumatoid arthritis, Crohn's disease; gene therapy of amyotrophic lateral sclerosis; drug creening; sustained release for prevent oxidative damage from superoxide buildup
07/31/2008US20080181864 Reducing mitochondrial membrane potential in mammalian cell by administering an major histocompatibility complex (MHC) class II HLA-DR (human leukocyte antigen) ligand; control disease by manipulating mitochondrial metabolism; drug screening antitumor drug; treating human breast cancer
07/31/2008US20080181850 detecting the presence or absence of expression neuroligin messenger RNA or polypeptides in tumor tissues or blood of humans suspected of having prostate cancer; screening for antisense agents or drugs; medical diagnosis
07/31/2008US20080181849 Methods, kits and compositions comprising crotamine
07/31/2008US20080181819 high flow properties and a low dead volume; integrated system that comprises molecular traps, such as affinity microcolumns, derivatized mass spectrometer targets, mass spectrometers capable of multi-sample input and robotics with processing/data analysis interactive database software
07/31/2008DE102007005053A1 Verfahren zur enzymatischen Herstellung von Wasserstoffperoxid Process for the enzymatic production of hydrogen peroxide
07/31/2008DE102007004624A1 Computer-aided simulation of chemical or biochemical reaction kinetics, involves specifying one or multiple molecular reactions of reaction kinetics by molecule types, reaction types and interaction constant, involved in molecular reaction
07/31/2008DE102006007249B4 Verfahren zur Bestimmung von Blasenkarzinomen des Differenzierungsgrades G2 A method for determining the degree of differentiation of bladder cancer G2
07/31/2008DE102005011003B4 Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren Method and means for the differential diagnosis of thyroid tumors
07/31/2008CA2676570A1 Nucleic acid sequencing system and method
07/31/2008CA2676559A1 Gene expression profiling for identification, monitoring, and treatment of lupus erythematosus
07/31/2008CA2676436A1 Diagnosis of prostate cancer
07/31/2008CA2676329A1 Detecting analytes using both an optical and an electrical measurement method
07/31/2008CA2676244A1 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
07/31/2008CA2675521A1 Human cancer stem cells